--- title: "Wai Yuen Tong Issues Profit Warning Amid Market Challenges" type: "News" locale: "en" url: "https://longbridge.com/en/news/266185694.md" description: "Wai Yuen Tong Medicine Holdings Limited has issued a profit warning, expecting a significant profit decline for the six months ending September 2025, from HK$23.7 million to HK$3.0 million. The decrease is due to weakened consumer sentiment, reduced net gains from property disposals, and lower net fair value gains on investment properties. The company has partially offset the impact through reduced administrative expenses and finance costs." datetime: "2025-11-17T11:39:16.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/266185694.md) - [en](https://longbridge.com/en/news/266185694.md) - [zh-HK](https://longbridge.com/zh-HK/news/266185694.md) --- # Wai Yuen Tong Issues Profit Warning Amid Market Challenges ### Meet Your ETF AI Analyst - Discover how TipRanks' _ETF_ AI Analyst can help you make smarter investment decisions - Explore ETFs TipRanks' users love and see what insights the **_ETF_ AI Analyst** reveals about the ones you follow. An update from Wai Yuen Tong Medicine Holdings Limited ( (HK:0897) ) is now available. Wai Yuen Tong Medicine Holdings Limited has issued a profit warning, indicating a significant decrease in profit for the six months ending September 2025. The expected decline from approximately HK$23.7 million to HK$3.0 million is attributed to weakened consumer sentiment, reduced net gains from property disposals, and lower net fair value gains on investment properties. Despite these challenges, the company managed to partially offset the impact through reduced administrative expenses and finance costs. The most recent analyst rating on (HK:0897) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Wai Yuen Tong Medicine Holdings Limited stock, see the HK:0897 Stock Forecast page. **More about Wai Yuen Tong Medicine Holdings Limited** Wai Yuen Tong Medicine Holdings Limited is a company incorporated in Bermuda with limited liability, listed on the Hong Kong Stock Exchange. The company operates in the pharmaceutical industry, focusing on the production and sale of traditional Chinese medicine products. **Average Trading Volume:** 1,228,008 **Technical Sentiment Signal:** Buy **Current Market Cap:** HK$511.9M Learn more about 0897 stock on TipRanks’ Stock Analysis page. ### Related Stocks - [00897.HK](https://longbridge.com/en/quote/00897.HK.md) ## Related News & Research - [Wai Yuen Tong Announces Board Meeting to Review Interim Results](https://longbridge.com/en/news/265310948.md) - [Keppel and Midea to collaborate on AI-enabled modular cooling solutions opportunities](https://longbridge.com/en/news/282548556.md) - [Franklin Templeton's Gamba on Growing ETF Offerings](https://longbridge.com/en/news/282312458.md) - [US ETF assets under management to more than double to $25T by 2030, Citigroup says](https://longbridge.com/en/news/282368377.md) - [VTSAX vs VOO ETF: Which Vanguard Fund Should You Buy in 2026?](https://longbridge.com/en/news/282456410.md)